SCHEMBL30725464

SCHEMBL30725464

Nc1ccc(Cn2cc(Nc3ncc(Cl)c(OC(F)F)n3)cn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 10/20 0.50
HDAC1 Q13547 10/20 0.50
HDAC6 Q9UBN7 9/20 0.50
JAK2 O60674 8/20 0.49
HDAC4 P56524 6/20 0.49
HDAC7 Q8WUI4 6/20 0.49
HDAC2 Q92769 6/20 0.49
HDAC10 Q969S8 6/20 0.49
HDAC11 Q96DB2 6/20 0.49
HDAC8 Q9BY41 6/20 0.49
HDAC9 Q9UKV0 6/20 0.49
HDAC5 Q9UQL6 6/20 0.49
KDR P35968 1/20 0.41
AURKB Q96GD4 1/20 0.41
MAP3K7 O43318 3/20 0.40
JAK3 P52333 4/20 0.39
MAPK1 P28482 2/20 0.39
MAP2K1 Q02750 2/20 0.39
FLT3 P36888 2/20 0.39
FLT4 P35916 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29174614 1.00 HDAC3 (0.50) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL29174625 0.85 HDAC3 (0.49) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL29174651 0.85 HDAC3 (0.42) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL29174686 0.82 JAK3 (0.59) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL30725550 0.82 HDAC3 (0.55) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL29174645 0.82 HDAC3 (0.55) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL30725482 0.80 JAK2 (0.51) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL29174660 0.80 JAK2 (0.51) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL30725437 0.77 HDAC3 (0.51) HDAC3HDAC1HDAC6JAK2HDAC4
SCHEMBL29174734 0.77 HDAC3 (0.51) HDAC3HDAC1HDAC6JAK2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430589-A 2-aminopyrimidine compound or salt thereof, and preparation method and application thereof 励缔(杭州)医药科技有限公司 2024-01-23 CN disclosed